Anja Cengia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Anja Cengia has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Svenja M. Spuling
German Centre of Gerontology
2 shared publications - Agnes Kisser
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication Anne Ingeborg Berg
Department of Psychology and Centre for Ageing and Health (AgeCap), University of Gothenburg
1 shared publication- Caoimhe Cawley
Pfizer Pharma GmbH, Berlin, Germany
1 shared publication - Ferras Alashkar
Department of Hematology and Stem Cell Transplantation, West German Cancer Center University Hospital Essen, University of Duisburg‐Essen Essen Germany
1 shared publication - Georg Henning
German Centre of Gerontology, Berlin, Germany
1 shared publication
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in Annals of Hematology
- Vol. 105 (11) , 478
Sickle cell disease in Germany – trends in epidemiology, healthcare utilization and disease burden from 2015 to 2024: a claims data analysis
Background: Sickle cell disease (SCD) is a rare inherited hemoglobinopathy associated with substantial morbidity and high healthcare needs. In Germany, population-based evidence on SCD epidemiology and real-world care patterns remains limited, despite increasing relevance in the context of migration and the introduction of nationwide newborn screening in 2021. Methods: We conducted a retrospective, non-interventional study using anonymized German statutory health insurance claims data from the InGef database (2015–2024). Patients with SCD were identified using ICD-10-GM codes D57.0, D57.1, D57.2, and D57.8 based on inpatient and confirmed outpatient diagnoses. Administrative prevalence was estimated using a carry-forward cohort approach, whereby SCD patients diagnosed in the current year and alive/observable in subsequent years were counted as prevalent. Administrative incidence was assessed in children aged < 6 years using the first recorded SCD diagnosis in claims data as the date of incidence. Analyses of patient characteristics, clinical outcomes, treatments and healthcare resource use (HCRU) were conducted cross-sectionally by calendar year, stratified by age group and sex. Results: Across 2015–2024, 1,019 individuals with SCD were identified. As might be expected using a carry forward cohort approach, annual prevalent counts increased from 225 (2015) to 864 (2024), and nationally extrapolated prevalence increased from 2.75 per 100,000 in 2015 to 10.50 per 100,000 in 2024. Median time to recorded diagnosis in children < 6 years decreased from 31 months (2015) to 11 months from 2021 onwards (2021–2024). In 2024, infections were the most frequently documented clinical outcome (34.5% [298/864]), followed by vaso‑occlusive crises (19.2% [166/864]) and mental health comorbidities (depression 19.1% [165/864]; anxiety 9.1% [79/864]). The proportions of patients with inpatient or outpatient visits, and with medication prescriptions (e.g. for antibiotics, antirheumatics, hydroxyurea), decreased over time. Conclusion: This claims-based analysis indicates increasing documented SCD prevalence in Germany. However, the extent to which prevalence increased due to a true increase in the general population, due to our carry-forward cohort approach, or due to other factors such as changes in coding practices or healthcare seeking behaviors, cannot be disentangled.We observed earlier recorded diagnosis timing in young children over time, alongside substantial age-dependent burden reflected in complications, mental health comorbidity, and healthcare utilization. Possible explanations for lower proportions of patients with inpatient/outpatient visits and medication prescriptions over time may include changes in disease awareness, patient management and/or healthcare seeking behaviours over time, and/or broader capture of patients with milder disease. Overall, our findings can inform healthcare planning and structured life-course–oriented SCD care pathways in Germany.
- 23 October 2026
- Published by Springer Nature in Annals of Hematology
- Vol. 105 (11) , 478
Open AccessSickle cell disease in Germany – trends in epidemiology, healthcare utilization and disease burden from 2015 to 2024: a claims data analysis
Background: Sickle cell disease (SCD) is a rare inherited hemoglobinopathy associated with substantial morbidity and high healthcare needs. In Germany, population-based evidence on SCD epidemiology and real-world care patterns remains limited, despite increasing relevance in the context of migration and the introduction of nationwide newborn screening in 2021. Methods: We conducted a retrospective, non-interventional study using anonymized German statutory health insurance claims data from the InGef database (2015–2024). Patients with SCD were identified using ICD-10-GM codes D57.0, D57.1, D57.2, and D57.8 based on inpatient and confirmed outpatient diagnoses. Administrative prevalence was estimated using a carry-forward cohort approach, whereby SCD patients diagnosed in the current year and alive/observable in subsequent years were counted as prevalent. Administrative incidence was assessed in children aged < 6 years using the first recorded SCD diagnosis in claims data as the date of incidence. Analyses of patient characteristics, clinical outcomes, treatments and healthcare resource use (HCRU) were conducted cross-sectionally by calendar year, stratified by age group and sex. Results: Across 2015–2024, 1,019 individuals with SCD were identified. As might be expected using a carry forward cohort approach, annual prevalent counts increased from 225 (2015) to 864 (2024), and nationally extrapolated prevalence increased from 2.75 per 100,000 in 2015 to 10.50 per 100,000 in 2024. Median time to recorded diagnosis in children < 6 years decreased from 31 months (2015) to 11 months from 2021 onwards (2021–2024). In 2024, infections were the most frequently documented clinical outcome (34.5% [298/864]), followed by vaso‑occlusive crises (19.2% [166/864]) and mental health comorbidities (depression 19.1% [165/864]; anxiety 9.1% [79/864]). The proportions of patients with inpatient or outpatient visits, and with medication prescriptions (e.g. for antibiotics, antirheumatics, hydroxyurea), decreased over time. Conclusion: This claims-based analysis indicates increasing documented SCD prevalence in Germany. However, the extent to which prevalence increased due to a true increase in the general population, due to our carry-forward cohort approach, or due to other factors such as changes in coding practices or healthcare seeking behaviors, cannot be disentangled.We observed earlier recorded diagnosis timing in young children over time, alongside substantial age-dependent burden reflected in complications, mental health comorbidity, and healthcare utilization. Possible explanations for lower proportions of patients with inpatient/outpatient visits and medication prescriptions over time may include changes in disease awareness, patient management and/or healthcare seeking behaviours over time, and/or broader capture of patients with milder disease. Overall, our findings can inform healthcare planning and structured life-course–oriented SCD care pathways in Germany.
- 1 September 2021
- Published by American Psychological Association (APA) in Psychology and Aging
- Vol. 36 (6) , 730-743
Do neuroticism and conscientiousness interact with health conditions in predicting 4-year changes in self-rated health among Swedish older adults?
Health conditions such as higher disease burden, pain, or lower functional health are associated with poorer self-rated health (SRH) in older age. Poorer SRH, in turn, is a predictor of morbidity and mortality. Personality traits are associated with SRH as well, but little is known about the interaction of personality and health conditions. In the present preregistered analyses, we used five annual waves of the Health, Aging and Retirement Transitions in Sweden (HEARTS) study (N = 5,823, M age = 63.09, SD = 2.01) to investigate the associations of personality (neuroticism and conscientiousness) and physical health indices (disease burden, pain, and functional limitations) with levels and change in SRH. In addition, we tested Personality × Health interaction effects. We found that higher neuroticism and lower conscientiousness were related to lower levels of SRH, but not to change in SRH after controlling for the health indices. Personality did not moderate the effect of health indices on levels and change in SRH. Exploratory analyses showed that high scores of neuroticism may augment the association of increased pain and functional limitations with declines in SRH. Additional studies with other samples are needed to test if this result can be replicated. Taken together, our findings provide only weak evidence for interaction effects of personality and physical health factors on SRH. More research is needed to understand the interplay of physical and psychological factors in shaping individual SRH. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
- 1 September 2021
- Published by American Psychological Association (APA) in Psychology and Aging
- Vol. 36 (6) , 730-743
Do neuroticism and conscientiousness interact with health conditions in predicting 4-year changes in self-rated health among Swedish older adults?
Health conditions such as higher disease burden, pain, or lower functional health are associated with poorer self-rated health (SRH) in older age. Poorer SRH, in turn, is a predictor of morbidity and mortality. Personality traits are associated with SRH as well, but little is known about the interaction of personality and health conditions. In the present preregistered analyses, we used five annual waves of the Health, Aging and Retirement Transitions in Sweden (HEARTS) study (N = 5,823, M age = 63.09, SD = 2.01) to investigate the associations of personality (neuroticism and conscientiousness) and physical health indices (disease burden, pain, and functional limitations) with levels and change in SRH. In addition, we tested Personality × Health interaction effects. We found that higher neuroticism and lower conscientiousness were related to lower levels of SRH, but not to change in SRH after controlling for the health indices. Personality did not moderate the effect of health indices on levels and change in SRH. Exploratory analyses showed that high scores of neuroticism may augment the association of increased pain and functional limitations with declines in SRH. Additional studies with other samples are needed to test if this result can be replicated. Taken together, our findings provide only weak evidence for interaction effects of personality and physical health factors on SRH. More research is needed to understand the interplay of physical and psychological factors in shaping individual SRH. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
- 1 May 2021
- Published by American Psychological Association (APA) in Psychology and Aging
- Vol. 36 (3) , 322-337
Feeling younger as a stress buffer: Subjective age moderates the effect of perceived stress on change in functional health.
Feeling younger than one's chronological age is associated with various beneficial health outcomes. However, apart from these direct health effects, little is known about the role of subjective age as a potential "buffer" and compensatory resource that might counteract the detrimental effect of health risk factors. We investigated whether the effect of perceived stress as a major health risk factor on change in functional health is smaller among individuals who feel younger. Additionally, we analyzed whether this "stress buffer effect" of subjective age varies by chronological age. Longitudinal data from the German Ageing Survey comprising 3 years (2014-2017) were used (N = 5,039; mean age at baseline: M = 63.91 years, SD = 10.80 years, range 40-95 years). Latent change score models revealed that, controlling for baseline functional health as well as for sociodemographic variables, greater perceived stress was associated with a steeper decline in functional health. This effect increased in size with advancing chronological age. Moreover, a younger subjective age was associated with a less steep decline in functional health. Subjective age additionally exhibited a stress buffer effect: Among individuals who felt younger, the association of greater perceived stress with steeper functional health decline was weaker. This stress buffer effect of subjective age became larger with increasing age. Our findings thus suggest that, particularly among older adults, a younger subjective age might help to buffer functional health decline, not only by directly affecting functional health, but also by compensating and counteracting the detrimental effect of stress on functional health. (PsycInfo Database Record (c) 2021 APA, all rights reserved).
- 1 May 2021
- Published by American Psychological Association (APA) in Psychology and Aging
- Vol. 36 (3) , 322-337
Feeling younger as a stress buffer: Subjective age moderates the effect of perceived stress on change in functional health.
Feeling younger than one's chronological age is associated with various beneficial health outcomes. However, apart from these direct health effects, little is known about the role of subjective age as a potential "buffer" and compensatory resource that might counteract the detrimental effect of health risk factors. We investigated whether the effect of perceived stress as a major health risk factor on change in functional health is smaller among individuals who feel younger. Additionally, we analyzed whether this "stress buffer effect" of subjective age varies by chronological age. Longitudinal data from the German Ageing Survey comprising 3 years (2014-2017) were used (N = 5,039; mean age at baseline: M = 63.91 years, SD = 10.80 years, range 40-95 years). Latent change score models revealed that, controlling for baseline functional health as well as for sociodemographic variables, greater perceived stress was associated with a steeper decline in functional health. This effect increased in size with advancing chronological age. Moreover, a younger subjective age was associated with a less steep decline in functional health. Subjective age additionally exhibited a stress buffer effect: Among individuals who felt younger, the association of greater perceived stress with steeper functional health decline was weaker. This stress buffer effect of subjective age became larger with increasing age. Our findings thus suggest that, particularly among older adults, a younger subjective age might help to buffer functional health decline, not only by directly affecting functional health, but also by compensating and counteracting the detrimental effect of stress on functional health. (PsycInfo Database Record (c) 2021 APA, all rights reserved).